688358 祥生医疗
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)6.65910.07310.9218.2729.225
总资产报酬率 ROA (%)5.9179.0089.6487.2698.187
投入资产回报率 ROIC (%)6.3309.75410.6498.0498.927

边际利润分析
销售毛利率 (%)59.82158.95458.08459.28456.291
营业利润率 (%)30.90133.56133.52830.23131.429
息税前利润/营业总收入 (%)25.85524.72928.61922.82632.293
净利润/营业总收入 (%)27.36929.97830.27527.79228.273

收益指标分析
经营活动净收益/利润总额(%)93.46789.86285.94877.59552.547
价值变动净收益/利润总额(%)2.7374.0118.34910.96514.072
营业外收支净额/利润总额(%)-0.749-0.289-0.018-0.001-0.391

偿债能力分析
流动比率 (X)8.2188.4249.6927.1049.091
速动比率 (X)7.5277.6678.7106.0598.380
资产负债率 (%)11.23711.04710.07713.23810.907
带息债务/全部投入资本 (%)5.3353.3161.2641.7661.737
股东权益/带息债务 (%)1,763.2882,895.8047,725.4705,511.7055,598.318
股东权益/负债合计 (%)789.948805.215892.369655.383816.839
利息保障倍数 (X)-5.369-2.831-5.836-3.08332.737

营运能力分析
应收账款周转天数 (天)141.638121.45092.287108.388118.501
存货周转天数 (天)237.599245.378295.449344.073190.007